CRISPR Cas专利文件，第4部分：一切归零，再想想！

IF 3.9 2区生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Journal of biotechnology Pub Date : 2025-08-23 DOI:10.1016/j.jbiotec.2025.08.001

Ulrich Storz

{"title":"CRISPR Cas专利文件，第4部分：一切归零，再想想！","authors":"Ulrich Storz","doi":"10.1016/j.jbiotec.2025.08.001","DOIUrl":null,"url":null,"abstract":"<div><div>The epic patent disputes regarding CRISPR Cas9 have been keeping the Biotech community abuzz over the last 10 years. The unclear situation has created, and keeps creating, serious uncertainties among users of this groundbreaking technology. This article gives an overview of the dispute’s history, and explains the actual state of the debate.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"407 ","pages":"Pages 78-86"},"PeriodicalIF":3.9000,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The CRISPR Cas patent files, part 4: All back to zero, think again!\",\"authors\":\"Ulrich Storz\",\"doi\":\"10.1016/j.jbiotec.2025.08.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The epic patent disputes regarding CRISPR Cas9 have been keeping the Biotech community abuzz over the last 10 years. The unclear situation has created, and keeps creating, serious uncertainties among users of this groundbreaking technology. This article gives an overview of the dispute’s history, and explains the actual state of the debate.</div></div>\",\"PeriodicalId\":15153,\"journal\":{\"name\":\"Journal of biotechnology\",\"volume\":\"407 \",\"pages\":\"Pages 78-86\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168165625001968\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168165625001968","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

在过去的10年里，关于CRISPR Cas9的史诗般的专利纠纷一直让生物技术界议论纷纷。这种不明朗的情况已经并将继续在这项突破性技术的用户中造成严重的不确定性。本文概述了争议的历史，并解释了争论的实际状态。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The CRISPR Cas patent files, part 4: All back to zero, think again!

The epic patent disputes regarding CRISPR Cas9 have been keeping the Biotech community abuzz over the last 10 years. The unclear situation has created, and keeps creating, serious uncertainties among users of this groundbreaking technology. This article gives an overview of the dispute’s history, and explains the actual state of the debate.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of biotechnology 工程技术-生物工程与应用微生物

CiteScore

8.90

自引率

2.40%

发文量

190

审稿时长

45 days

期刊介绍： The Journal of Biotechnology has an open access mirror journal, the Journal of Biotechnology: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The Journal provides a medium for the rapid publication of both full-length articles and short communications on novel and innovative aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case the material is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome.